Related references
Note: Only part of the references are listed.Green tea epigallocatechin-3-gallate inhibits angiogenesis and suppresses vascular endothelial growth factor C/vascular endothelial growth factor receptor 2 expression and signaling in experimental endometriosis in vivo
Hui Xu et al.
FERTILITY AND STERILITY (2011)
Mechanistic issues concerning cancer prevention by tea catechins
Chung S. Yang et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2011)
Antitumor activity of novel fluoro-substituted (-)-epigallocatechin-3-gallate analogs
Huanjie Yang et al.
CANCER LETTERS (2010)
Celastrol Suppresses Angiogenesis-Mediated Tumor Growth through Inhibition of AKT/Mammalian Target of Rapamycin Pathway
Xiufeng Pang et al.
CANCER RESEARCH (2010)
(-)-Epigallocatechin gallate inhibits growth and activation of the VEGF/VEGFR axis in human colorectal cancer cells
Masahito Shimizu et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2010)
Green Tea and Cancer Prevention
Chung S. Yang et al.
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL (2010)
(-)-Epigallocatechin gallate suppresses the growth of human hepatocellular carcinoma cells by inhibiting activation of the vascular endothelial growth factor-vascular endothelial growth factor receptor axis
Yohei Shirakami et al.
CANCER SCIENCE (2009)
Cancer prevention by tea: animal studies, molecular mechanisms and human relevance
Chung S. Yang et al.
NATURE REVIEWS CANCER (2009)
Multitargeted therapy of cancer by green tea polyphenols
Naghma Khan et al.
CANCER LETTERS (2008)
Grape Seed Extract Inhibits Angiogenesis via Suppression of the Vascular Endothelial Growth Factor Receptor Signaling Pathway
Wei Wen et al.
CANCER PREVENTION RESEARCH (2008)
Synergistic inhibition of lung tumorigenesis by a combination of green tea polyphenols and atorvastatin
Gang Lu et al.
CLINICAL CANCER RESEARCH (2008)
Methylation suppresses the proteasome-inhibitory function of green tea polyphenols
Kristin R. Landis-Piwowar et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2007)
A novel prodrug of the green tea polyphenol (-)-epigallocatechin-3-gallate as a potential anticancer agent
Kristin R. Landis-Piwowar et al.
CANCER RESEARCH (2007)
A component of green tea, (-)-epigallocatechin-3-gallate, promotes apoptosis in T24 human bladder cancer cells via modulation of the PI3K/Akt pathway and Bcl-2 family proteins
Jie Qin et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Green tea polyphenols and its constituent epigallocatechin gallate inhibits proliferation of human breast cancer cells in vitro and in vivo
Rajesh L. Thangapazham et al.
CANCER LETTERS (2007)
Peracetylation as a means of enhancing in vitro bioactivity and bioavailability of epigallocatechin-3-gallate
Joshua D. Lambert et al.
DRUG METABOLISM AND DISPOSITION (2006)
Green tea catechin, epigallocatechin-3-gallate, inhibits vascular endothelial growth factor angiogenic signaling by disrupting the formation of a receptor complex
SK Rodriguez et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Inhibition of intestinal tumorigenesis in Apcmin/+ mice by (-)-epigallocatechin-3-gallate, the major catechin in green tea
J Ju et al.
CANCER RESEARCH (2005)
Mechanisms of inhibition of tumor angiogenesis and vascular tumor growth by epigallocatechin-3-gallate
G Fassina et al.
CLINICAL CANCER RESEARCH (2004)
Clinical translation of angiogenesis inhibitors
R Kerbel et al.
NATURE REVIEWS CANCER (2002)
Tea catechins inhibit angiogenesis endothelial cell growth, migration in vitro, measured by human and tube formation, through inhibition of VEGF receptor binding
T Kondo et al.
CANCER LETTERS (2002)
Degradation of green tea catechins in tea drinks
ZY Chen et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2001)
Antioxidative activity of (-)-epigallocatechin-3-(3-O-methyl)gallate isolated from fresh tea leaf and preliminary results on its biological activity
M Kawase et al.
BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY (2000)